Trials
Search / Trial NCT05643547

Immunophenotypic Evaluation of IL-7R α in Acute Leukaemia

Launched by RANIA ABDELTWAB ABDELAZEIM · Nov 30, 2022

Trial Information

Current as of February 05, 2025

Unknown status

Keywords

ClinConnect Summary

Acute leukemia is generally understood to be a neoplastic process that exerts a maturational block at a hematopoietic precursor cell level, accompanied by a proliferative drive of varying degree. The resulting accumulation of cells, most frequently in the marrow, causes the typical clinical picture, which includes marrow failure, tissue infiltration, organomegaly and on occasion, tumor masses. AL is broadly classified as acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL) (1).

Acute lymphoblastic leukemia is frequently diagnosed in children and young adults, with incidence peaks...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Newly diagnosed patients with Acute leukemia (ALL, AML), male or female at any age.
  • Exclusion Criteria:
  • Patients diagnosed with hematological malignancy other than acute leukemias
  • Patients receiving chemo and/or radiotherapy
  • Patients on steroid therapy for any other reason
  • Patients receiving any immunosuppressive drug

About Rania Abdeltwab Abdelazeim

Rania Abdeltwab Abdelazeim is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic approaches, she oversees the design, implementation, and management of clinical trials, ensuring compliance with regulatory standards and ethical guidelines. Her expertise in clinical research and collaboration with multidisciplinary teams facilitates the seamless execution of studies, aiming to contribute valuable insights to the medical community. Rania’s leadership is characterized by a patient-centered approach, fostering an environment of safety and integrity throughout the research process.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials